title: Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin.
abstract: Diaspirin crosslinked hemoglobin (DCLHb), a hemoglobin based oxygen carrying solution prepared from outdated human blood, is subjected to a heat treatment step to inactivate viruses in our manufacturing process. To validate the efficacy of this inactivation, we have simulated the heat treatment procedure at a reduced scale using hemoglobin solution spiked with representative viruses. Human Immuno-deficiency Virus (HIV), Cytomegalovirus (CMV), and Duck Hepatitis B Virus (DHBV) were used in this validation. Inoculation with concentrated virus was performed just prior to the heat treatment to determine the effect of that specific process step. Samples were taken before, during, and after heat treatment and assayed for virus titer in an attempt to assess the rate as well as the extent of virus inactivation. CMV was analyzed in a plaque assay using MRC-5 indicator cells. The titer was reduced from 3.3 x 10(6) plaque forming units (PFU) per mL to less than 5 x 10(1) PFU/mL (detection limit) within 30 minutes. DHBV was analyzed by inoculation of serially diluted samples into Pekin ducklings, followed at intervals by screening sera for DHBV DNA by dot blot hybridization. The titer was reduced from 5.0 x 10(6) duck infectious units (DIU) per mL to less than 5 x 10(0) DIU/mL (detection limit) within 1 hour. HIV titers were determined through an ELISA assay for p24 antigen present in peripheral blood lymphocyte cocultivation supernatants. The titer was reduced from 2.0 x 10(4) infectious units (IU) per mL to less than 2 x 10(0) IU/mL (detection limit) within 1 hour. These data indicate that high titers of these blood borne viruses are rapidly inactivated by this heat treatment process.
authors.affiliation: Baxter Healthcare Corporation, Round Lake, IL.
authors.forename: M
authors.initials: M
authors.lastname: Farmer
authors.forename: A
authors.initials: A
authors.lastname: Ebeling
authors.forename: T
authors.initials: T
authors.lastname: Marshall
authors.forename: W
authors.initials: W
authors.lastname: Hauck
authors.forename: C S
authors.initials: CS
authors.lastname: Sun
authors.forename: E
authors.initials: E
authors.lastname: White
authors.forename: Z
authors.initials: Z
authors.lastname: Long
mesh_terms: D001241:Aspirin / Q000031:analogs & derivatives; D001802:Blood Substitutes / Q000302:isolation & purification*; D003432:Cross-Linking Reagents; D003587:Cytomegalovirus / Q000302:isolation & purification; D004340:Drug Contamination; D005069:Evaluation Studies as Topic; D006678:HIV / Q000302:isolation & purification; D006454:Hemoglobins / Q000302:isolation & purification*; D015611:Hepatitis B Virus, Duck / Q000302:isolation & purification; D006358:Hot Temperature; D006801:Humans; D014780:Viruses / Q000302:isolation & purification*
chemical_list: D001802:Blood Substitutes; D003432:Cross-Linking Reagents; D006454:Hemoglobins; C030830:succinyldisalicylic acid; D001241:Aspirin